Fulgent Genetics, Inc.
NASDAQ: FLGT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ming Hsieh
- Employees
- 1,313
- Headquarters
- El Monte, United States
- IPO year
- 2016
- Market cap
- $543.3M
- Website
- https://www.fulgentgenetics.com
Loading FLGT…
Loading profile data…Frequently asked questions about FLGT
What does Fulgent Genetics, Inc. (FLGT) do?
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular prof...
Where does FLGT trade?
Fulgent Genetics, Inc. (FLGT) trades on the NASDAQ Global Market.
What sector is FLGT in?
Fulgent Genetics, Inc. (FLGT) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Fulgent Genetics, Inc.?
Ming Hsieh is the chief executive officer of Fulgent Genetics, Inc. (FLGT).
Where is Fulgent Genetics, Inc. headquartered?
Fulgent Genetics, Inc. is headquartered in United States.
Does FLGT pay a dividend?
Fulgent Genetics, Inc. (FLGT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FLGT go public?
Fulgent Genetics, Inc. (FLGT) completed its initial public offering in 2016.